Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research

Keyphrases

Publications

volume 27, number 7, 2024

Yilin Chen, Peter Martin, Lurdes Y T Inoue, Anirban Basu, Josh J Carlson
Tackling Challenges in Assessing the Economic Value of Tumor-Agnostic Therapies: A Cost-Effectiveness Analysis of Pembrolizumab as a Case Study. Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 27 (7) (2024)
Matthew Walton, Laura Bojke, Mark Simmonds, Ruth Walker, Alexis Llewellyn, Helen Fulbright, Sofia Dias, Lesley A Stewart, Tom Rush, David H Steel, John G Lawrenson, Tunde Peto, Robert Hodgson
Anti-Vascular Endothelial Growth Factor Drugs Compared With Panretinal Photocoagulation for the Treatment of Proliferative Diabetic Retinopathy: A Cost-Effectiveness Analysis. Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 27 (7) (2024)
Caterina Gregorio, Federico Rea, Francesca Ieva, Arjuna Scagnetto, Carla Indennidate, Chiara Cappelletto, Andrea Di Lenarda, Giulia Barbati
Flexible Approaches Based on Multistate Models and Microsimulation to Perform Real-World Cost-Effectiveness Analyses: An Application to Proprotein Convertase Subtilisin-Kexin Type 9 Inhibitors. Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 27 (7) (2024)
Caterina Gregorio, Federico Rea, Francesca Ieva, Arjuna Scagnetto, Carla Indennidate, Chiara Cappelletto, Andrea Di Lenarda, Giulia Barbati
Flexible Approaches Based on Multistate Models and Microsimulation to Perform Real-World Cost-Effectiveness Analyses: An Application to Proprotein Convertase Subtilisin-Kexin Type 9 Inhibitors. Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 27 (7) (2024)
Aleksandra Torbica, Brendan Mulhern, Richard Norman
Understanding the Complex Interactions Between Interventions, Well-Being, and Resource Allocation. Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 27 (7) (2024)
Ling Jie Cheng, Tianxin Pan, Le Ann Chen, Jing Ying Cheng, Brendan Mulhern, Nancy Devlin, Nan Luo
The Ceiling Effects of EQ-5D-3L and 5L in General Population Health Surveys: A Systematic Review and Meta-Analysis. Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 27 (7) (2024)
Sarkis Manoukian, Helen Mason, Suzanne Hagen, Rohna Kearney, Kirsteen Goodman, Catherine Best, Andrew Elders, Lynn Melone, Lucy Dwyer, Melanie Dembinsky, Aethele Khunda, Karen Lesley Guerrero, Doreen McClurg, John Norrie, Ranee Thakar, Carol Bugge
Cost-Effectiveness of 2 Models of Pessary Care for Pelvic Organ Prolapse: Findings From the TOPSY Randomized Controlled Trial. Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 27 (7) (2024)
Francesco Longo, Karl Claxton, Susan Griffin, Anne Mason, Simon Walker, Helen Weatherly
Social Decision-Making Analysis: A General Approach to Inform Decisions on Resources in the Public Sector. Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 27 (7) (2024)
Cindy L Gauvreau, Leighton Schreyer, Paul J Gibson, Alicia Koo, Wendy J Ungar, Dean Regier, Kelvin Chan, Robin Hayeems, Jennifer Gibson, Antonia Palmer, Stuart Peacock, Avram E Denburg
Development of a Value Assessment Framework for Pediatric Health Technologies Using Multicriteria Decision Analysis: Expanding the Value Lens for Funding Decision Making. Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 27 (7) (2024)
Salah Ghabri, Dalia Dawoud, Michael Drummond
Methods for Including Adverse Events in Economic Evaluations: Suggestions for Improvement. Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 27 (7) (2024)

volume 27, number 8, 2024

Amelia Smith, Karen Finnigan, Sarah Clarke, Michael Barry, Claire Gorry
Utilization, Expenditure, and Treatment Patterns Associated With Calcitonin Gene-Related Peptide Monoclonal Antibodies Reimbursed Subject to a Managed Access Protocol in Ireland. Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 27 (8) (2024)
William V Padula, Peter Kolchinsky
Can Generalized Cost-Effectiveness Analysis Leverage Meaningful Use of Novel Value Elements in Pharmacoeconomics to Inform Medicare Drug Price Negotiation? Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 27 (8) (2024)
Dan-Lin Li, Zi-Tong Wang, Xin-Yi Nie, Nan Luo, Yi-Bo Wu, Chen-Wei Pan, Pei Wang
EQ-5D-5L Population Norms for China Derived From a National Health Survey. Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 27 (8) (2024)
Louis P Garrison, Boshen Jiao, Zizi Elsisi, Alon Yehoshua, Roy Koruth, Bruce Kreter, Jens Grueger
Estimating the Allocation of the Economic Value Generated by Utilization of All-Oral Direct-Acting Antivirals for Hepatitis C in the United States, 2015 to 2019. Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 27 (8) (2024)
Marcelien H E Callenbach, Daphne Schoenmakers, Rick A Vreman, Sylvia Vijgen, Lonneke Timmers, Carla E M Hollak, Aukje K Mantel-Teeuwisse, Wim G Goettsch
Illustrating the Financial Consequences of Outcome-Based Payment Models From a Payers Perspective: The Case of Autologous Gene Therapy Atidarsagene Autotemcel (Libmeldy®). Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 27 (8) (2024)
Dylan Maciel, Jeroen P Jansen, Sven L Klijn, Kevin Towle, Devender Dhanda, Bill Malcolm, Shannon Cope
Implementing Multilevel Network Meta-Regression for Time-To-Event Outcomes: A Case Study in Relapsed Refractory Multiple Myeloma. Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 27 (8) (2024)
Xavier G L V Pouwels, Karel Kroeze, Naomi van der Linden, Michelle M A Kip, Hendrik Koffijberg
Validating Health Economic Models With the Probabilistic Analysis Check dashBOARD. Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 27 (8) (2024)
Amelia Smith, Karen Finnigan, Sarah Clarke, Michael Barry, Claire Gorry
Utilization, Expenditure, and Treatment Patterns Associated With Calcitonin Gene-Related Peptide Monoclonal Antibodies Reimbursed Subject to a Managed Access Protocol in Ireland. Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 27 (8) (2024)
Gengchen Ye, Yanan Zhu, Wenrui Bao, Heping Zhou, Jiandong Lai, Yuchen Zhang, Juanping Xie, Qingbo Ma, Zhaoyao Luo, Shaohui Ma, Yichu Guo, Xuanting Zhang, Ming Zhang, Xuan Niu
The Long COVID Symptoms and Severity Score: Development, Validation, and Application. Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 27 (8) (2024)
Kednapa Thavorn, Emily Rose Thompson, Srishti Kumar, Aliisa Heiskanen, Anubhav Agarwal, Harold Atkins, Risa Shorr, Terry Hawrysh, Kelvin Kar-Wing Chan, Justin Presseau, Daniel A Ollendorf, Ian D Graham, Jeremy M Grimshaw, Manoj Mathew Lalu, Surapon Nochaiwong, Dean A Fergusson, Brian Hutton, Doug Coyle, Natasha Kekre
Economic Evaluations of Chimeric Antigen Receptor T-Cell Therapies for Hematologic and Solid Malignancies: A Systematic Review. Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 27 (8) (2024)
Michael J DiStefano, Steven D Pearson, David M Rind, Antal Zemplenyi
How Do the Institute for Clinical and Economic Review's Assessments of Comparative Effectiveness Compare With the German Federal Joint Committee's Assessments of Added Benefit? A Qualitative Study. Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 27 (8) (2024)
Eric Andrew Finkelstein, Semra Ozdemir, Vinh Anh Huynh, Junxing Chay, Axel Mühlbacher, Hiang Khoon Tan
Navigating Public Policy Responses to a Pandemic: The Balancing Act Between Physical Health, Mental Health, and Household Income. Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 27 (8) (2024)
Olalekan O Oluwole, Markqayne D Ray, Katherine L Rosettie, Graeme Ball, Jorge Jacob, S Pinar Bilir, Anik R Patel, Caron A Jacobson
Cost-Effectiveness of Axicabtagene Ciloleucel for Adult Patients With Relapsed or Refractory Follicular Lymphoma in the United States. Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 27 (8) (2024)
Adrian Towse, Elisabeth Fenwick
It Takes 2 to Tango. Setting Out the Conditions in Which Performance-Based Risk-Sharing Arrangements Work for Both Parties. Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 27 (8) (2024)
Laura A Trigg, G J Melendez-Torres, Ahmed Abdelsabour, Dawn Lee
Treatment Effect Waning Assumptions: A Review of National Institute of Health and Care Excellence Technology Appraisals. Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 27 (8) (2024)
Paul Arora, Alind Gupta, Emma Mackay, Bart Heeg, Kristian Thorlund
The Inflation Reduction Act: An Opportunity to Accelerate Confidence in Real-World Evidence in the United States. Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 27 (8) (2024)
Bernhard Michalowsky, Lidia Engel, Maresa Buchholz, Niklas Weber, Thomas Kohlmann, Feng Xie
Health Fluctuations in Dementia and its Impact on the Assessment of Health-Related Quality of Life Using the EQ-5D-5L. Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 27 (8) (2024)
William V Padula, Peter Kolchinsky
Can Generalized Cost-Effectiveness Analysis Leverage Meaningful Use of Novel Value Elements in Pharmacoeconomics to Inform Medicare Drug Price Negotiation? Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 27 (8) (2024)
Xue Li, Rui Li, Meixuan Li, Liang Yao, Harriette Van Spall, Kun Zhao, Yunxiang Chen, Feiyi Xiao, Qiang Fu, Feng Xie
A Systematic Review and Quality Assessment of Cardiovascular Disease-Specific Health-Related Quality-of-Life Instruments Part I: Instrument Development and Content Validity. Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 27 (8) (2024)

volume 27, number 9, 2024

Bram Roudijk, Marcel F Jonker, Henry Bailey, Eleanor Pullenayegum
A Direct Comparison Between Discrete Choice With Duration and Composite Time Trade-Off Methods: Do They Produce Similar Results? Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 27 (9) (2024)
Myriam Mirza, Lutz Goerke, Anna Anderson, Tim Wilsdon
Assessing the Cost-Effectiveness of Next-Generation Sequencing as a Biomarker Testing Approach in Oncology and Policy Implications: A Literature Review. Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 27 (9) (2024)
Claire Hutchinson, Julie Ratcliffe, Jenny Cleland, Rachel Milte, Amanda Muller, Marleesa Ly, Natalie Hannaford, Jyoti Khadka
Further Evidence of Feasibility, Validity, and Reliability of Quality of Life-Aged Care Consumers: Evidence From Home-Based Care Settings. Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 27 (9) (2024)
Anouk S Huberts, Linetta B Koppert, Joica A M Benschop, Jelle W Meerstra, Adriaan van 't Spijker, Céline van Lint, Nadia C W Kamminga, Monique S den Hollander, Ingrid A Peters, Christien J van der Woude
Facilitators and Barriers in the Implementation and Adoption of Patient-Reported Outcomes Measurements in Daily Practice. Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 27 (9) (2024)
Shiro Tanaka, Ataru Igarashi, Raf De Moor, Nan Li, Mariko Hirozane, Li Wen Hong, David Bin-Chia Wu, Dae Young Yu, Mahmoud Hashim, Brian Hutton, Krista Tantakoun, Christopher Olsen, Fatemeh Mirzayeh Fashami, Imtiaz A Samjoo, Chris Cameron
A Targeted Review of Worldwide Indirect Treatment Comparison Guidelines and Best Practices. Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 27 (9) (2024)
Jamie Elvidge, Claire Hawksworth, Tuba Saygın Avşar, Antal Zemplenyi, Anastasia Chalkidou, Stavros Petrou, Zsuzsanna Petykó, Divya Srivastava, Gunjan Chandra, Julien Delaye, Alastair Denniston, Manuel Gomes, Saskia Knies, Petros Nousios, Pekka Siirtola, Junfeng Wang, Dalia Dawoud, null null
Consolidated Health Economic Evaluation Reporting Standards for Interventions That Use Artificial Intelligence (CHEERS-AI). Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 27 (9) (2024)
Abigail G Riley, Dominic Voehler, Rachel Mitrovich, Cristina Carias, Daniel A Ollendorf, Katherine L Nelson, Patricia G Synnott, Amanda L Eiden
Documenting the Full Value of Vaccination: A Systematic Review of Value Frameworks. Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 27 (9) (2024)
Meixia Liao, Zhihao Yang, Kim Rand, Nan Luo
Testing "Pits" Time Trade-Off: Can Data Quality be Improved by Removing Death From Valuation of Health States? Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 27 (9) (2024)
Joseph A Dottino, Katharine M Esselen, Rebecca Costa, Stephanie Argetsinger, Mahnum Shahzad, Dennis Ross-Degnan, Anita K Wagner
Financial Toxicity of Withdrawn Poly (Adenosine Diphosphate Ribose) Polymerase Inhibitor Indications for Ovarian Cancer. Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 27 (9) (2024)
Lidia Engel, Nikki McCaffrey, Cathrine Mihalopoulos, Anne Muldowney, Brendan Mulhern, Jemimah Ride
Putting a Dollar Value on Informal Care Time Provided to People Living With Dementia: A Discrete Choice Experiment. Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 27 (9) (2024)
Abigail G Riley, Dominic Voehler, Rachel Mitrovich, Cristina Carias, Daniel A Ollendorf, Katherine L Nelson, Patricia G Synnott, Amanda L Eiden
Documenting the Full Value of Vaccination: A Systematic Review of Value Frameworks. Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 27 (9) (2024)
Darius Lakdawalla, Sean Tunis, Peter Neumann, Danielle Whicher, Emily Zeitler, Barry Liden
A Roadmap for Improving Medicare's Application of Coverage With Evidence Development. Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 27 (9) (2024)
Shiro Tanaka, Ataru Igarashi, Raf De Moor, Nan Li, Mariko Hirozane, Li Wen Hong, David Bin-Chia Wu, Dae Young Yu, Mahmoud Hashim, Brian Hutton, Krista Tantakoun, Christopher Olsen, Fatemeh Mirzayeh Fashami, Imtiaz A Samjoo, Chris Cameron
A Targeted Review of Worldwide Indirect Treatment Comparison Guidelines and Best Practices. Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 27 (9) (2024)
Jose-Maria Abellan-Perpiñan, Jorge-Eduardo Martinez-Perez, Fernando-Ignacio Sanchez-Martinez, Jose-Luis Pinto-Prades
A Feasible Estimation of a "Corrected" EQ-5D Social Tariff. Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 27 (9) (2024)
Marie-Lien Gerits, Samantha Bielen, Dorien Lanssens, Janis Luyten, Wilfried Gyselaers, null null
Experience Counts: Unveiling Patients' Willingness to Pay for Remote Monitoring and Patient Self-Measurement. Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 27 (9) (2024)
Myriam Mirza, Lutz Goerke, Anna Anderson, Tim Wilsdon
Assessing the Cost-Effectiveness of Next-Generation Sequencing as a Biomarker Testing Approach in Oncology and Policy Implications: A Literature Review. Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 27 (9) (2024)
Emily McDool, Clara Mukuria, Tessa Peasgood
Psychometric Performance of the EQ Health and Wellbeing Short in a United Kingdom Population Sample. Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 27 (9) (2024)
Marie-Lien Gerits, Samantha Bielen, Dorien Lanssens, Janis Luyten, Wilfried Gyselaers, null null
Experience Counts: Unveiling Patients' Willingness to Pay for Remote Monitoring and Patient Self-Measurement. Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 27 (9) (2024)
Jamie Elvidge, Claire Hawksworth, Tuba Saygın Avşar, Antal Zemplenyi, Anastasia Chalkidou, Stavros Petrou, Zsuzsanna Petykó, Divya Srivastava, Gunjan Chandra, Julien Delaye, Alastair Denniston, Manuel Gomes, Saskia Knies, Petros Nousios, Pekka Siirtola, Junfeng Wang, Dalia Dawoud, null null
Consolidated Health Economic Evaluation Reporting Standards for Interventions That Use Artificial Intelligence (CHEERS-AI). Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 27 (9) (2024)
Bruce E Sands, Julian Panés, Brian G Feagan, Hongyan Zhang, Marion L Vetter, Susan D Mathias, Kuan-Hsiang Gary Huang, Jewel Johanns, Matthew Germinaro, Aparna Sahoo, Natalie A Terry, Chenglong Han
Qualitative and Psychometric Evaluation of 29-Item Patient-Reported Outcomes Measurement Information System® to Assess General Health-Related Quality of Life in Patients With Moderately to Severely Active Inflammatory Bowel Disease. Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 27 (9) (2024)
Jamie Elvidge, Claire Hawksworth, Tuba Saygın Avşar, Antal Zemplenyi, Anastasia Chalkidou, Stavros Petrou, Zsuzsanna Petykó, Divya Srivastava, Gunjan Chandra, Julien Delaye, Alastair Denniston, Manuel Gomes, Saskia Knies, Petros Nousios, Pekka Siirtola, Junfeng Wang, Dalia Dawoud, null null
Consolidated Health Economic Evaluation Reporting Standards for Interventions That Use Artificial Intelligence (CHEERS-AI). Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 27 (9) (2024)